Centre to supply around 19.2 mn vaccine doses to states during May 16-31

The allocation of Central supplies to the states is decided on the consumption pattern and beneficiary load for second doses during the upcoming fortnight, says govt

astra
Photo: Bloomberg
BS Web Team New Delhi
1 min read Last Updated : May 14 2021 | 2:19 PM IST
The Central government will supply around 19.2 million vaccine doses to states and union territories (UTs) during the fortnight of May 16-31. This will include 16.2 million doses of Covishield and 2.9 million of Covaxin.

"The allocation of Central supplies to the states is decided on the consumption pattern and beneficiary load for second doses during the upcoming fortnight," said the health ministry on Friday.

"The delivery schedule for this allocation will be shared in advance. States have been requested to direct the concerned officials to ensure rational and judicious utilization of allocated doses and minimize the vaccine wastage," it said.

After 118 days of vaccination drive, the cumulative number of vaccine doses administered in the country is nearly 180 million. 

The government says India is the fastest country globally to reach the 170 million target in 114 days. USA took 115 days and China took 119 days to administer the same amount of doses.

However, if we look at vaccinations as a percentage of population, India is way behind the developed world and many states are reporting severe shortages and halting vaccinations.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story